Literature DB >> 8013347

Treatment of IM-9 cells with human growth hormone (GH) promotes rapid disulfide linkage of the GH receptor.

S J Frank1, G Gilliland, C Van Epps.   

Abstract

Human GH (hGH) is believed to elicit its signal by promoting dimerization of the hGH receptor (hGHR). In this study, we examined a covalent linkage of receptors induced by hGH treatment of IM-9 cells. hGH induced a time- and concentration-dependent appearance of a disulfide-linked species of 215-230 kilodaltons, designated p215-230, that at 37 C was long-lived (> 1 h). p215-230 was confirmed to contain the hGHR (115-140 kilodaltons) as at least one of its constituents by two-dimensional diagonal sodium dodecyl sulfate-polyacrylamide gel electrophoresis. hGH induction of p215-230 required intact cells and was inhibitable by pretreatment of cells with N-ethylmaleimide (NEM), a sulfhydryl-reactive alkylating agent. NEM pretreatment did not, however, prevent hGH-dependent formation of a nondisulfide-linked p215-230 form, which was detected in NEM-pretreated hGH-stimulated cells by chemical cross-linking of detergent cell extracts. The disulfide-linked form of the hGHR accounted for a substantial fraction of the receptors that became tyrosine phosphorylated early into hGH treatment. However, formation of the disulfide-linked hGHR was not blocked by attenuation of tyrosine kinase activation, in that pretreatment of cells with staurosporine (1.25 microM) prevented detectable hGH-induced tyrosine phosphorylation without preventing the appearance of p215-230. These findings indicate that hGH induces its receptor to form a noncovalently associated complex, which then undergoes a rapid transition to a disulfide-linked form. These processes may have relevance to hGH signaling and/or hGHR trafficking.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013347     DOI: 10.1210/endo.135.1.8013347

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions.

Authors:  M A Adelsman; B K Huntley; N J Maihle
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

2.  Dynamic analysis of GH receptor conformational changes by split luciferase complementation.

Authors:  Ying Liu; Philip A Berry; Yue Zhang; Jing Jiang; Peter E Lobie; Ramasamy Paulmurugan; John F Langenheim; Wen Y Chen; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-04

3.  Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.

Authors:  Jie Xu; Yue Zhang; Philip A Berry; Jing Jiang; Peter E Lobie; John F Langenheim; Wen Y Chen; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2011-02-10

4.  Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues.

Authors:  Luqin Deng; Jing Jiang; Stuart J Frank
Journal:  Endocrinology       Date:  2012-03-13       Impact factor: 4.736

5.  Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping.

Authors:  Jing Jiang; Yu Wan; Xiangdong Wang; Jie Xu; Jonathan M Harris; Peter E Lobie; Yu Zhang; Kurt R Zinn; Michael J Waters; Stuart J Frank
Journal:  Endocrinology       Date:  2011-10-11       Impact factor: 4.736

6.  Multimeric growth hormone receptor complexes serve as signaling platforms.

Authors:  Magdalena Sedek; Lieke M van der Velden; Ger J Strous
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

7.  Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.

Authors:  Ning Yang; John F Langenheim; Xiangdong Wang; Jing Jiang; Wen Y Chen; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2007-12-20

8.  Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.

Authors:  Xiangdong Wang; Ning Yang; Luqin Deng; Xin Li; Jing Jiang; Yujun Gan; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2009-01-22

Review 9.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

Review 10.  Prolactin receptor antagonists.

Authors:  C B Kuo; D Coss; A M Walker
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.